ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H(HK:1541)
HK$2.88+0.01 (+0.52%)
HK:1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H financials statements
HK$2.88
At close:+0.01 (+0.52%)
Want to see HK:1541 full AI Analyst Report?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) Income Statement
3 Followers
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Income Statement
Last quarter (Q2 2026), ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H's total revenue was ¥37.25M, an increase of 5075.31% from the same quarter last year. In Q2, ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H's net income was ¥-164.19M. See ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 150.30M | ¥ 74.15M | ¥ 386.00K | ¥ 5.69M | ¥ 13.81M | |
| ¥ 134.99M | ¥ 74.15M | ¥ 7.70M | ¥ 5.69M | ¥ 13.81M | |
| ¥ 352.25M | ¥ 382.19M | ¥ 372.37M | ¥ 370.14M | ¥ 224.27M | |
| Depreciation and Amortization | ¥ 14.23M | ¥ 20.68M | ¥ 22.58M | ¥ 17.62M | ¥ 13.18M |
| ¥ -203.03M | ¥ -287.36M | ¥ -355.35M | ¥ -384.49M | ¥ -718.88M | |
| ¥ -217.26M | ¥ -308.04M | ¥ -364.67M | ¥ -364.45M | ¥ -210.47M | |
| ¥ 3.68M | ¥ -8.55M | ¥ -14.79M | ¥ -38.44M | ¥ -522.48M | |
| ¥ -213.58M | ¥ -316.59M | ¥ -379.46M | ¥ -402.89M | ¥ -732.95M | |
| ¥ -212.92M | ¥ -315.86M | ¥ -379.46M | ¥ -402.89M | ¥ -732.95M | |
| Per Share Metrics | |||||
| Basic EPS | ¥ -0.51 | ¥ -0.84 | ¥ -1.05 | ¥ -1.08 | ¥ -1.96 |
| Diluted EPS | ¥ -0.51 | ¥ -0.84 | ¥ -1.05 | ¥ -1.08 | ¥ -1.96 |
| Weighted Average Shares Outstanding | 412.44M | 377.15M | 361.81M | 373.24M | 373.24M |
| Weighted Average Shares Outstanding (Diluted) | 412.44M | 377.15M | 361.81M | 373.24M | 373.24M |
Currency in CNY

